Douglas Faget

August 14, 2023

Douglas has a background in cancer biology and immuno-oncology and brings an innovative approach to the biology team to advance new immunotherapies. At Pheast, Douglas studies cellular mechanisms and functions in the setting of immuno-oncology. During his postdoctoral training at Washington University in St. Louis, he worked with various mouse models of metastatic and primary breast cancer to investigate the role of stress-induced pathways in the tumor immune microenvironment. Specifically, this study identified a new immunotherapy combination that was effective to treat metastatic breast cancer in mouse models. Douglas received a M.Sc. and Ph.D. in Oncology from the Brazilian National Cancer Institute and a bachelor’s degree in Medical Biology from the Federal University of Rio de Janeiro.